Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Abbott | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Abbott

Humira sales up 8%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott

2Q Revenues: $9.8 billion (+2%)

2Q Earnings: $1.7 billion (-11%)

YTD Revenues: $19.3 billion (+3%)

YTD Earnings: $3.0 billion (+6%)

Comments: Proprietary Pharmaceutical sales were $8.5 billion (+1%) in the quarter. Established Pharmaceutical sales were $2.5 billion (-6%). Humira sales were up 8% to $2.3 billion in the quarter. TRILIPIX/TriCor sales were down 12% to $388 million. AndroGel sales were down 10% to $284 million. Kaletra sales dropped 20% to $275 million. Lupron sales were down 14% to $200 million. Nutritionals business grew 6% to $1.6 billion driven by U.S. sales up 13% to $741 million. Results include a 4.7% unfavorable impact from foreign exchange.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters